Cite
Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting in Clear Cell Renal Cell Carcinoma.
MLA
Pan, Hong, et al. “Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting in Clear Cell Renal Cell Carcinoma.” Cancer Biotherapy & Radiopharmaceuticals, vol. 34, no. 5, June 2019, pp. 334–41. EBSCOhost, https://doi.org/10.1089/cbr.2018.2697.
APA
Pan, H., Hong, Y., Yu, B., Li, L., & Zhang, X. (2019). Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting in Clear Cell Renal Cell Carcinoma. Cancer Biotherapy & Radiopharmaceuticals, 34(5), 334–341. https://doi.org/10.1089/cbr.2018.2697
Chicago
Pan, Hong, Yejing Hong, Biying Yu, Li Li, and Xiaojian Zhang. 2019. “Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting in Clear Cell Renal Cell Carcinoma.” Cancer Biotherapy & Radiopharmaceuticals 34 (5): 334–41. doi:10.1089/cbr.2018.2697.